| Yongwoo Kim, MD | |
|
3800 Reservoir Rd Nw, Washington, DC 20007 | |
| (202) 877-3791 | |
| (202) 877-2166 |
| Full Name | Yongwoo Kim |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 16 Years |
| Location | 3800 Reservoir Rd Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396092250 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Medstar Saint Mary's Hospital | Leonardtown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mgmc Llc | 9537073119 | 412 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into a strategic agreement with Harlan Biotech Israel Ltd (HBI), a leading Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company's innovative therapy for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease).
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, HIV/AIDS, announced today that it has filed a provisional patent application in the United States for its humanized version of its lead product Cytolin, a monoclonal antibody for the treatment of HIV infection.
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers at the Spanish National Center for Cardiovascular Research have discovered that the ends of heart muscle cell chromosomes rapidly erode after birth, limiting the cells' ability to proliferate and replace damaged heart tissue.
Despite the positive results of small studies and a widely held belief in its benefit, the practice of keeping female patients immobilised after intrauterine insemination has no beneficial effect on pregnancy rates, according to results of a large randomised study presented here at the Annual Meeting of ESHRE in Helsinki.
› Verified 5 days ago
| Entity Name | Mgmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891797148 PECOS PAC ID: 9537073119 Enrollment ID: O20031220000056 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into a strategic agreement with Harlan Biotech Israel Ltd (HBI), a leading Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company's innovative therapy for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease).
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, HIV/AIDS, announced today that it has filed a provisional patent application in the United States for its humanized version of its lead product Cytolin, a monoclonal antibody for the treatment of HIV infection.
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers at the Spanish National Center for Cardiovascular Research have discovered that the ends of heart muscle cell chromosomes rapidly erode after birth, limiting the cells' ability to proliferate and replace damaged heart tissue.
Despite the positive results of small studies and a widely held belief in its benefit, the practice of keeping female patients immobilised after intrauterine insemination has no beneficial effect on pregnancy rates, according to results of a large randomised study presented here at the Annual Meeting of ESHRE in Helsinki.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yongwoo Kim, MD 3800 Reservoir Rd Nw, Washington, DC 20007-2113 Ph: (202) 877-3791 | Yongwoo Kim, MD 3800 Reservoir Rd Nw, Washington, DC 20007 Ph: (202) 877-3791 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into a strategic agreement with Harlan Biotech Israel Ltd (HBI), a leading Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company's innovative therapy for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease).
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, HIV/AIDS, announced today that it has filed a provisional patent application in the United States for its humanized version of its lead product Cytolin, a monoclonal antibody for the treatment of HIV infection.
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers at the Spanish National Center for Cardiovascular Research have discovered that the ends of heart muscle cell chromosomes rapidly erode after birth, limiting the cells' ability to proliferate and replace damaged heart tissue.
Despite the positive results of small studies and a widely held belief in its benefit, the practice of keeping female patients immobilised after intrauterine insemination has no beneficial effect on pregnancy rates, according to results of a large randomised study presented here at the Annual Meeting of ESHRE in Helsinki.
› Verified 5 days ago
Mr. Joel Edward Kleinman, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3734 Jenifer St Nw, Washington, DC 20015 Phone: 202-363-4846 Fax: 202-363-2025 | |
Dr. John Shill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2220 20th St Nw, Ste 71, Washington, DC 20009 Phone: 202-320-4417 | |
Nubia Amparo Chong, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1300 I St Nw Ste 400e, Washington, DC 20005 Phone: 202-902-7324 Fax: 848-213-0063 | |
Dr. Jerrold Thomas O'rourke Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1330 New Hampshire Ave Nw, Ste 113, Washington, DC 20036 Phone: 202-463-6634 Fax: 202-463-6638 | |
Dr. Jaime Suarez, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2401 E Street Nw - M/med/qi - Sa-1, Department Of State, Washington, DC 20522 Phone: 202-663-2453 Fax: 202-663-3247 | |
Dr. Estela M. Gonzalez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2333 Ontario Rd Nw, Washington, DC 20009 Phone: 202-420-7121 | |
Dr. Richard Martin Restak, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1800 R St Nw, Suite C-3, Washington, DC 20009 Phone: 202-462-0455 Fax: 202-462-0340 |